Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Funding types
Funding types
Shareholder Investment
Products 1 to 10 of 129
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Accellerase TRIO
by
DuPont
+
Genencor
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/20 09:09 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
ActoBiotics: AG013 (Oral Mucositis)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Government
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
ActoBiotics: AG017 (Celiac Disease)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/16 16:28 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
ActoBiotics: AG018 (Rhinosinusitus)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
ActoBiotics: AG019 (Type 1 Diabetes)
by
Actobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
ActoBiotics: AG020 (Inflammatory Bowel Disease)
by
Actiobio Therapeutics
Biotech components:
Bacteria
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (5 years ago)
Date last modified:
2019/09/12 15:12 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Algae food ingredients (AlgaeVia, AlgaePur, AlgaWise)
by
Corbion
+
TerreVia
+
Solazyme
Biotech components:
Plant
Business models:
B2C
Country of production:
Netherlands
Country of distribution:
USA
+
Netherlands
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:58 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
CRBN
(AEX)
Value chain stage:
Finished Product
Antibiotic - EV-035
by
Emergent Biosolutions, Inc.
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Switzerland
Intended consumer:
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
AquAdvantage Salmon (#2)
by
AquaBounty
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/06 10:13 (6 years ago)
Known funding amount:
38,000,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
AQB
(NASDAQ)
Value chain stage:
Finished Product
Arctic Apple
by
Okanagan Specialty Fruits
+
Intrexon
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 15:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
XON
(NYSE)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
8
9
10
…
13
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
